Shifting Preferences: Why U.S. Hemp Consumers Choose THCA Pre‑Rolls Over Loose Flower in 2026
A recent survey conducted by Exhale Wellness reveals a clear movement among hemp users toward ready‑to‑smoke THCA pre‑rolls. The online poll of 200 U.S. consumers aged 21 and older, fielded between June 1 and June 7 2026, shows that 70 % of respondents are purchasing more pre‑rolls than they did a year ago, while 30 % report buying less loose flower over the same period. These figures underline a growing preference for products that combine convenience, consistent potency, and verifiable lab results.
Survey Insights on Convenience and Consistency
The Exhale Wellness 2026 THCA Pre‑Roll Demand Survey asked participants to rank the factors influencing their purchase decisions. The results, presented in the table below, highlight convenience as the leading driver:
| Survey Finding | Result |
| Pre‑roll buyers who cite convenience and ‘no grinding’ as a top reason | 70% |
| Pre‑roll buyers who cite consistent size and dosing in every joint | 20% |
| Respondents reaching for loose THCA flower less than a year ago | 10% |
Source: Exhale Wellness 2026 THCA Pre‑Roll Demand Survey
The data show that convenience and consistency work hand‑in‑hand. A loose jar requires grinding, measuring, and rolling by hand—steps that can be time‑consuming and prone to waste. Pre‑rolls eliminate those steps, allowing users to move from package to first puff in seconds. For consumers who smoke a few times each week, the saved effort accumulates into a meaningful advantage.
What Drives the Pre‑Roll Appeal?
Beyond the raw numbers, several practical benefits explain why shoppers are gravitating toward pre‑rolled joints:
| Driver | What It Means for Buyers |
| Convenience | No grinder, papers, or prep before the first puff |
| Consistent dosing | Each joint is packed to a similar weight, making effects easier to predict than hand‑rolled flower |
| Freshness | Sealed packaging protects the flower from air and light, preserving terpenes and cannabinoids |
| Portability | A finished joint travels more discreetly than a jar of loose flower |
| Variety | Single pre‑rolls let buyers try an indica one night and a sativa the next without committing to bulk purchases |
Single pre‑rolls also lower the barrier to experimentation. Instead of buying a multi‑pack of a single strain, consumers can purchase one indica and one sativa to see which fits their routine. This low‑risk sampling approach appeals to both first‑time and returning buyers.
Trust plays a pivotal role as well. Many shoppers tell Exhale they prefer a sealed, labeled pre‑roll that comes with a Certificate of Analysis (COA) over flower scooped from a jar. A COA is a third‑party lab report confirming the cannabinoid content on the label and screening for common contaminants. When the report backs the potency printed on the package, buyers know exactly what they are getting before they light up. Loose flower rarely travels with the same documentation once opened, making lab transparency a decisive factor in online brand comparisons.
Market Trends Supporting the Shift
Exhale Wellness’s findings align with broader industry data. According to a 2026 market report from Custom Cones USA, powered by analytics firm Headset, pre‑rolls have surpassed flower as the top cannabis category by units for the first time. The category generated an estimated $3.6 billion in revenue across more than 383 million units, representing a 15.9 % share of total sales.
Growth has been robust for five consecutive years. Pre‑roll unit sales rose 18.6 % year‑over‑year, while the broader cannabis market expanded just 1.5 %. Since 2021, pre‑roll revenue has more than doubled. Retail tracking from BDSA notes that flower and pre‑rolls were the only major categories to gain dollar sales year‑over‑year, indicating that consumers are concentrating their spending on these formats.
Infused pre‑rolls are leading the surge. Infused options accounted for 47 % of pre‑roll revenue and posted the fastest growth. Exhale’s two infused products—Baby J’s Triple Infused Strawberry Cough and Diamond Infused Gelato—sit squarely in this high‑potency, ready‑to‑smoke segment.
Low price points encourage trial. Single‑gram pre‑rolls remain the top‑selling product format, allowing consumers to experiment without a large financial outlay. The format also fits existing habits: smoking remains the most common consumption method, so a ready‑to‑smoke joint slots seamlessly into established routines. Millennials, a core demographic for the category, contributed nearly 44 % of pre‑roll revenue in the report, and pre‑rolls have already overtaken flower as the top‑selling cannabis category in Canada—a market often predictive of U.S. trends.
Hemp‑derived THCA is following the same trajectory. As pre‑rolls become easier to find and more consistent in quality, users who once rolled their own are shifting to finished joints. In the hemp space, a published COA provides the same confidence shoppers expect from licensed dispensaries.
Exhale Wellness’s 2026 THCA Pre‑Roll Lineup
Exhale Wellness offers six THCA pre‑rolls across indica, sativa, and hybrid strains, with labeled potency ranging from 34 % to 76 % THCA. Every pre‑roll uses freshly ground, USA‑grown hemp, wrapped in hemp paper with a wood‑pulp filter, and contains no tobacco or nicotine.
| Pre‑Roll | Strain Type | Labeled THCA | Price |
| Han Solo | Indica | 36% | $49.95 |
| Runtz | Hybrid | 35% | $49.95 |
| Gelato | Hybrid | 34% | $49.95 |
| Sex Panther | Sativa | 40% | $49.95 |
| Baby J’s Triple Infused (Strawberry Cough) | Sativa | 76% | $54.95 |
| Diamond Infused (Gelato) | Hybrid | Concentrate‑infused | $14.00 |
The four flower‑only options share a $49.95 price point, letting buyers choose by experience rather than cost. Han Solo indica holds a 4.92 out‑of‑5 rating across 13 reviews—the highest score in the line—while Sex Panther is the sativa pick at 40 % THCA. Two infused products deliver higher potency: Baby J’s Triple Infused Strawberry Cough at a labeled 76 % THCA and the single Diamond Infused Gelato pre‑roll at $14.00, offering a lower‑cost entry point for those curious about infused formats.
Strain selection remains part of the appeal. An indica pre‑roll like Han Solo is a common evening choice, whereas a sativa option such as Sex Panther suits daytime use. Each product page lists the strain type and labeled THCA potency, so buyers know what to expect before ordering. Every batch is third‑party tested for potency and pesticides, and Exhale posts the matching COA for each item at exhalewell.com/labs/. Customer ratings across the line range from the mid‑4 s to 4.92 out of 5.
Quality, Testing, and Compliance
Exhale Wellness emphasizes transparency as a cornerstone of its brand. All products are derived from organically grown, USA‑sourced hemp that complies with the Farm Bill—containing no more than 0.3 % Delta‑9 THC by dry weight. Each batch undergoes third‑party lab testing for potency and pesticides, and the corresponding Certificate of Analysis is published online before checkout. Buyers can review every COA to confirm that a pre‑roll matches its label, providing a straightforward method to verify Farm Bill compliance.
The company advises customers to check local regulations, as state rules for smokable hemp continued to evolve throughout 2026. Exhale’s website includes compliance details and recommends confirming legality in the buyer’s jurisdiction before placing an order.
Looking Ahead
Exhale Wellness plans to repeat its THCA pre‑roll demand survey in future years to track evolving preferences. As spokesperson Sarah Rudwik noted, “Pre‑rolls have moved from a convenience item to a primary format, and our 2026 survey tells the same story we hear from customers every day. People want something lab‑tested and ready to enjoy, without the work or guesswork of loose flower. That is squarely where demand is heading in 2026.”
For readers interested in the full press release and additional details, the original source is available below.
Source: Here
